As of 2025-08-18, the Intrinsic Value of Atlas Arteria Group (ALX.AX) is 2.77 AUD. This ALX.AX valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 5.27 AUD, the upside of Atlas Arteria Group is -47.50%.
The range of the Intrinsic Value is 1.51 - 6.60 AUD
Based on its market price of 5.27 AUD and our intrinsic valuation, Atlas Arteria Group (ALX.AX) is overvalued by 47.50%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 1.51 - 6.60 | 2.77 | -47.5% |
| DCF (Growth 10y) | 15.98 - 52.78 | 25.07 | 375.7% |
| DCF (EBITDA 5y) | 1.10 - 1.69 | 1.44 | -72.8% |
| DCF (EBITDA 10y) | 11.75 - 16.49 | 14.25 | 170.4% |
| Fair Value | 0.95 - 0.95 | 0.95 | -82.00% |
| P/E | 3.08 - 4.48 | 3.87 | -26.6% |
| EV/EBITDA | (0.88) - (0.69) | (0.79) | -115.1% |
| EPV | 0.27 - 0.69 | 0.48 | -90.9% |
| DDM - Stable | 1.99 - 7.84 | 4.92 | -6.7% |
| DDM - Multi | 53.51 - 151.38 | 77.80 | 1376.2% |
| Market Cap (mil) | 7,645.87 |
| Beta | 0.40 |
| Outstanding shares (mil) | 1,450.83 |
| Enterprise Value (mil) | 9,115.17 |
| Market risk premium | 5.10% |
| Cost of Equity | 7.42% |
| Cost of Debt | 5.00% |
| WACC | 6.92% |